What you will see is a slight rise on huge volume as people try to exit positions, and that will be the start of better times. Look for a few 40m volume days...
would be nice to see more info on how scientific community is reacting to the good phase 2 ... Surely there is interest after the June presentation to that respiratory conference that only had pre-final results. Surely this is validation of many years of academic work, and the reduced biomarkers a big deal for several major diseases.
Add to My Watchlist
What is My Watchlist?
